AtriCure (ATRC) News Today $32.36 -0.26 (-0.80%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$32.38 +0.02 (+0.06%) As of 04/15/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period JPMorgan Chase & Co. Purchases 110,039 Shares of AtriCure, Inc. (NASDAQ:ATRC)JPMorgan Chase & Co. boosted its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 43.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 365,183 shares of the medical device company's stock after acquiringApril 15 at 3:22 AM | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Stake Decreased by Grandeur Peak Global Advisors LLCGrandeur Peak Global Advisors LLC decreased its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 26.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 242,791 shares of the medical device compApril 14 at 7:15 AM | marketbeat.comArrowstreet Capital Limited Partnership Buys New Position in AtriCure, Inc. (NASDAQ:ATRC)Arrowstreet Capital Limited Partnership purchased a new position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 26,693 shares of the medical device company's sApril 14 at 3:37 AM | marketbeat.comAmerican Century Companies Inc. Makes New $516,000 Investment in AtriCure, Inc. (NASDAQ:ATRC)American Century Companies Inc. acquired a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 16,872 shares of the medical device company's stoApril 14 at 3:19 AM | marketbeat.comNorges Bank Invests $3.42 Million in AtriCure, Inc. (NASDAQ:ATRC)Norges Bank acquired a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 111,947 shares of the medical device company's stock, valued atApril 13 at 4:03 AM | marketbeat.comAtriCure launches smaller device for heart surgeryApril 12, 2025 | uk.investing.comKennedy Capital Management LLC Acquires 172,648 Shares of AtriCure, Inc. (NASDAQ:ATRC)Kennedy Capital Management LLC lifted its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 29.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 752,580 shares of the medical device company's stock after acquiring an additional 172,648 shaApril 12, 2025 | marketbeat.comAtriCure Announces First Use of the AtriClip PRO-Mini® DeviceApril 10, 2025 | finance.yahoo.comAtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Wellington Management Group LLPWellington Management Group LLP trimmed its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 57.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 654,504 shares of the medicalApril 9, 2025 | marketbeat.comDayton’s stocks continue loss streak following election and now tariffsApril 8, 2025 | bizjournals.comAtriCure to Announce First Quarter 2025 Financial ResultsApril 8, 2025 | finance.yahoo.comAtriCure Drops 25%: Bargain Or Caution Sign?April 8, 2025 | seekingalpha.comDynamic Technology Lab Private Ltd Invests $988,000 in AtriCure, Inc. (NASDAQ:ATRC)Dynamic Technology Lab Private Ltd purchased a new stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 32,330 shares of the medical device company's stock, vaApril 8, 2025 | marketbeat.comTrexquant Investment LP Buys 20,875 Shares of AtriCure, Inc. (NASDAQ:ATRC)Trexquant Investment LP raised its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 27.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 98,206 shares of the medical device company's stock afterApril 8, 2025 | marketbeat.comKLP Kapitalforvaltning AS Invests $321,000 in AtriCure, Inc. (NASDAQ:ATRC)KLP Kapitalforvaltning AS acquired a new stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 10,500 shares of the medical device company's stock,April 7, 2025 | marketbeat.comAstra Wealth Partners LLC Buys New Holdings in AtriCure, Inc. (NASDAQ:ATRC)Astra Wealth Partners LLC purchased a new position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 8,048 shares of the medical device company's stock, valued aApril 6, 2025 | marketbeat.comBryce Point Capital LLC Takes Position in AtriCure, Inc. (NASDAQ:ATRC)Bryce Point Capital LLC acquired a new position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 16,760 shares of the medical device company's stock, valued at approximately $512,000. Several othApril 6, 2025 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Short Interest Up 19.7% in MarchAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) was the target of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 1,700,000 shares, a growth of 19.7% from the February 28th total of 1,420,000 shares. Based on an average daily volume of 571,400 shares, the days-to-cover ratio is presently 3.0 days. Approximately 3.6% of the shares of the stock are sold short.April 4, 2025 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Alliancebernstein L.P.Alliancebernstein L.P. decreased its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 3.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,835,449 shares of the medical device company's stocApril 4, 2025 | marketbeat.comAtriCure (NASDAQ:ATRC) Shares Down 6.8% Following Analyst DowngradeAtriCure (NASDAQ:ATRC) Stock Price Down 6.8% Following Analyst DowngradeMarch 29, 2025 | marketbeat.comAtriCure (NASDAQ:ATRC) Price Target Lowered to $52.00 at Canaccord Genuity GroupCanaccord Genuity Group cut their price target on shares of AtriCure from $66.00 to $52.00 and set a "buy" rating on the stock in a research report on Friday.March 29, 2025 | marketbeat.comAtriCure price target raised to $58 from $57 at BTIGMarch 29, 2025 | markets.businessinsider.comAtriCure price target lowered to $52 from $66 at CanaccordMarch 29, 2025 | markets.businessinsider.comJPMorgan Chase & Co. Has Lowered Expectations for AtriCure (NASDAQ:ATRC) Stock PriceJPMorgan Chase & Co. decreased their price objective on shares of AtriCure from $51.00 to $46.00 and set an "overweight" rating for the company in a report on Thursday.March 28, 2025 | marketbeat.comAtriCure (NASDAQ:ATRC) Earns "Buy" Rating from Needham & Company LLCNeedham & Company LLC restated a "buy" rating and issued a $51.00 price target on shares of AtriCure in a research note on Thursday.March 28, 2025 | marketbeat.comRaymond James Financial Inc. Takes Position in AtriCure, Inc. (NASDAQ:ATRC)Raymond James Financial Inc. bought a new position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 121,591 shares of the medical device companMarch 28, 2025 | marketbeat.comAtriCure Highlights Growth and Innovation at Investor DayMarch 26, 2025 | tipranks.comAtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Emerald Advisers LLCEmerald Advisers LLC cut its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 77.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 89,098 shares of the medical device company's stock after selling 300,738 shares during theMarch 25, 2025 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Given Average Rating of "Buy" by BrokeragesAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) has received an average recommendation of "Buy" from the nine analysts that are presently covering the company, Marketbeat reports. Nine equities research analysts have rated the stock with a buy rating. The average 1-year price objective among analysMarch 25, 2025 | marketbeat.comRoyce & Associates LP Has $748,000 Stake in AtriCure, Inc. (NASDAQ:ATRC)Royce & Associates LP decreased its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 62.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,482 shares of the medical device company'sMarch 23, 2025 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Shares Sold by AmundiAmundi lowered its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 10.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 270,455 shares of the medical device company's stock after selling 31,3March 15, 2025 | marketbeat.comAtriCure (NASDAQ:ATRC) Share Price Passes Above Two Hundred Day Moving Average - What's Next?AtriCure (NASDAQ:ATRC) Shares Pass Above 200-Day Moving Average - Should You Sell?March 15, 2025 | marketbeat.comAtriCure (NASDAQ:ATRC) Shares Down 6% After Insider SellingAtriCure (NASDAQ:ATRC) Trading Down 6% Following Insider SellingMarch 8, 2025 | marketbeat.comKaren Prange Sells 6,100 Shares of AtriCure, Inc. (NASDAQ:ATRC) StockAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) Director Karen Prange sold 6,100 shares of the company's stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $38.12, for a total value of $232,532.00. Following the transaction, the director now directly owns 17,828 shares in the company, valued at approximately $679,603.36. This trade represents a 25.49 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.March 8, 2025 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Director Karen Prange Sells 6,100 SharesMarch 8, 2025 | insidertrades.comInsider Sell: Karen Prange Sells 6,100 Shares of AtriCure Inc (ATRC)March 7, 2025 | gurufocus.comVersor Investments LP Acquires Shares of 7,100 AtriCure, Inc. (NASDAQ:ATRC)Versor Investments LP bought a new position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 7,100 shares of the medical device company's stock, valued at approximately $217,000. SevMarch 5, 2025 | marketbeat.comY Intercept Hong Kong Ltd Decreases Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC)Y Intercept Hong Kong Ltd cut its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 31.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,997 shares of the medical device company's stock after selling 6,887 shares duMarch 3, 2025 | marketbeat.comRhumbline Advisers Has $2.41 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC)Rhumbline Advisers boosted its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 11.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 78,815 shares of the medical device company's stock after buyiMarch 3, 2025 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Buy" from BrokeragesShares of AtriCure, Inc. (NASDAQ:ATRC - Get Free Report) have received an average recommendation of "Buy" from the nine research firms that are currently covering the company, Marketbeat Ratings reports. Nine equities research analysts have rated the stock with a buy recommendation. The average twFebruary 28, 2025 | marketbeat.comCowa LLC Acquires Shares of 7,097 AtriCure, Inc. (NASDAQ:ATRC)Cowa LLC acquired a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 7,097 shares of the medical device company's stock, valued at approximately $217,000. A number of other institutionalFebruary 23, 2025 | marketbeat.comHighMark Wealth Management LLC Buys 13,500 Shares of AtriCure, Inc. (NASDAQ:ATRC)HighMark Wealth Management LLC lifted its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 19.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 83,725 shares of the medical device company's stockFebruary 18, 2025 | marketbeat.comAlphaCentric Advisors LLC Makes New Investment in AtriCure, Inc. (NASDAQ:ATRC)AlphaCentric Advisors LLC bought a new position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 26,035 shares of the medical device company's stock, valued at approximately $796,000. AlphaFebruary 17, 2025 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Sees Significant Decrease in Short InterestAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) was the target of a significant decrease in short interest in the month of January. As of January 31st, there was short interest totalling 1,170,000 shares, a decrease of 20.4% from the January 15th total of 1,470,000 shares. Based on an average trading volume of 480,400 shares, the short-interest ratio is presently 2.4 days.February 16, 2025 | marketbeat.comAtriCure Full Year 2024 Earnings: EPS Misses ExpectationsFebruary 14, 2025 | finance.yahoo.comAtriCure files automatic mixed securities shelfFebruary 14, 2025 | markets.businessinsider.comAtriCure, Inc. (NASDAQ:ATRC) Q4 2024 Earnings Call TranscriptFebruary 14, 2025 | msn.comHood River Capital Management LLC Increases Stake in AtriCure IncFebruary 14, 2025 | gurufocus.comAtriCure price target raised to $57 from $53 at BTIGFebruary 14, 2025 | markets.businessinsider.comAtriCure targets $517M-$527M revenue in 2025 with new product launches and international growthFebruary 13, 2025 | msn.com Remove Ads Get AtriCure News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter. Email Address ATRC Media Mentions By Week ATRC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATRC News Sentiment▼1.100.79▲Average Medical News Sentiment ATRC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATRC Articles This Week▼114▲ATRC Articles Average Week Remove Ads Get AtriCure News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TFX News Today ITGR News Today ATEC News Today IART News Today OFIX News Today SRDX News Today ANGO News Today ARAY News Today RMTI News Today RSLS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATRC) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AtriCure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AtriCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ATRC Stock Free ATRC Stock Alerts